,Variant_classification,Gene_classification,Comment,Difficultregion,CNV-SNV,ID,OMIM_Phenotype,Disease,Clinical_synopsis,OMIM_Link,Uniprot,Inheritance,Zygosity,CHR,POS,REF,ALT,Flank,Repeat_flag,FILTER,FORMAT,VAF,Pileup_data,Mutation_type,Gene_name,Entrez_Gene_Id,In_Key_Gene,HGVS_nomenclature,HGMD_transcript,ExonNumber,PolarChange,1000G_ASN_AF,1000G_ALL_AF,ESP6500_AC,ESP6500_AF,gnomAD_exome_ALL,gnomAD_exome_EAS,gnomAD_genome_ALL,gnomAD_genome_EAS,ExAC_EAS_HomoAlt_Count,ExAC_EAS_AC,ExAC_EAS_AF,ExAC_HomoAlt_Count,ExAC_AC,ExAC_AF,In_house_freq,In_house_count,ExAC_Link,ExAC_MisZ,ExAC_Expected,ExAC_observed,ExAC_PLI,PLI_Link,Phylop_Vertebrate_score,Phylop_Mammal_score,SIFT_score,SIFT_prediction,Polyphen2_HDIV_score,Polyphen2_HDIV_pred,Polyphen2_HVAR_score,Polyphen2_HVAR_pred,LRT_score,LRT_prediction,Mutationtatser_score,Mutationtatser_prediction,Gerp++,CADD,Rs_ID,Swiss_prot_function,Swiss_prot_disease_association,Swiss_prot_post_translational_modifications,Swiss_prot_expression,HGMD_mutation_type,HGMD_variant_class,HGMD_disease,HGMD_pubmed_ID,HGMD_indel_type,HGMD_Indel_class,HGMD_indel_disease,HGMD_indel_PMID,HGMD_nearby_alleles,Clinvar,Clinvar_Link,CosmicID,Cosmic_Occurence,Mother_zygosity,Mother_filter,Mother_format,Mother_VAF,Mother_pileup,Father_zygosity,Father_filter,Father_format,Father_VAF,Father_pileup,Recessive,Com_het,De_novo,Other_relatives,Covered,Less_20,GO_BP,GO_CC,GO_MF,KEGG_PATHWAY,PID_PATHWAY,BIOCARTA_PATHWAY,REACTOME_PATHWAY,pheno_rank,intersect_rank,CaseID
230,.,.,OMIM|low_frequency,.,.,AX257,616051,"?Microcephaly 13, primary, autosomal recessive","1.$$$mimNumber,616051###prefix,####preferredTitle,MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13###inheritance,Autosomal recessive ###growthHeight,Short stature (in 1 of 2 sibs) ###growthWeight,Low weight due to poor growth ###growthOther,Intrauterine growth retardation (IUGR) ###headAndNeckHead,Microcephaly (-7 to -9 SD) ###headAndNeckFace,Sloping forehead ;###headAndNeckFace,Low forehead ;###headAndNeckFace,Round face ;###headAndNeckFace,Micrognathia ###headAndNeckEars,Large appearing ears ###headAndNeckEyes,Nystagmus, intermittent (1 of 2 sibs) ###headAndNeckNose,Prominent nose ###cardiovascularHeart,Congenital restrictive cardiomyopathy (in 1 of 2 sibs) ###chestRibsSternumClaviclesAndScapulae,Widening of the ribs, mild (in 1 of 2 sibs) ###skeletalLimbs,Metaphyseal sclerosis, mild (in 1 of 2 sibs) ###skeletalHands,Small hands ###skeletalFeet,Small feet ###neurologicCentralNervousSystem,Delayed psychomotor development, moderate to severe ;###neurologicCentralNervousSystem,Seizures (in 1 of 2 sibs) ;###neurologicCentralNervousSystem,Simplified gyral pattern (in 1 of 2 sibs) ;###neurologicCentralNervousSystem,Partial agenesis of the corpus callosum (in 1 of 2 sibs) ;###neurologicCentralNervousSystem,Cerebellar hypoplasia (in 1 of 2 sibs) ###miscellaneous,Two sibs have been reported (last curated October 2014) ###molecularBasis,Caused by mutation in the centromeric protein E gene (CENPE, )",https://www.omim.org/entry/616051,.,Autosomal recessive,Het,4,104061079,G,A,.,.,PASS,0/1:35:84,41.67,"A.,A,,a.A,AA,,aA.A,...aaAA,a,AAA,a,,A.A.,,A,.,aaAa..,,,,,..a,,a,,Aa,,.,.,,,aa,A^]a",missense_variant,CENPE,1062,.,NM_001813.2(CENPE):c.6071C>T(p.Thr2024Ile),NM_001813.2,exon38(49),P0=>NP,.,0.0002,0,0,1.627e-05,0.0002,.,.,0,3,0.00035,0,4,0.000033,.,.,http://exac.broadinstitute.org/variant/4-104061079-G-A,-1.14,91.1,20,0.65,http://exac.broadinstitute.org/gene/ENSG00000138778,0.35226,.,0.07,T,0.987,D,0.67,P,.,.,1.000,N,1.52,12.64,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886)|ATP catabolic process (GO:0006200)|blood coagulation (GO:0007596)|kinetochore assembly (GO:0051382)|metabolic process (GO:0008152)|microtubule-based movement (GO:0007018)|mitotic cell cycle (GO:0000278)|mitotic chromosome movement towards spindle pole (GO:0007079)|mitotic metaphase plate congression (GO:0007080)|multicellular organismal development (GO:0007275)|positive regulation of protein kinase activity (GO:0045860)|regulation of mitotic metaphase/anaphase transition (GO:0030071),"chromosome (GO:0005694)|chromosome, centromeric region (GO:0000775)|condensed chromosome outer kinetochore (GO:0000940)|condensed chromosome, centromeric region (GO:0000779)|condensed nuclear chromosome kinetochore (GO:0000778)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|kinesin complex (GO:0005871)|kinetochore (GO:0000776)|membrane (GO:0016020)|microtubule (GO:0005874)|microtubule cytoskeleton (GO:0015630)|midbody (GO:0030496)|mitotic spindle midzone (GO:1990023)|nucleus (GO:0005634)",ATP binding (GO:0005524)|ATPase activity (GO:0016887)|kinetochore binding (GO:0043515)|microtubule motor activity (GO:0003777),.,.,.,.,55,2,AX257
324,.,.,OMIM|novel,.,.,AX257,208000;615522;125853;613312;601665,"Arterial calcification, generalized, of infancy, 1;Cole disease;Diabetes mellitus, non-insulin-dependent, susceptibility to;Hypophosphatemic rickets, autosomal recessive, 2;Obesity, susceptibility to","1.$$$mimNumber,208000###prefix,####preferredTitle,ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1###inheritance,Autosomal recessive ###growthHeight,Short stature (in some patients) ###headAndNeckEars,Deafness, conductive (in some patients) ###headAndNeckEyes,Angioid retinal streaks (in some patients) ###headAndNeckNeck,Pseudoxanthomatous skin lesions (in some patients) ###cardiovascularHeart,Coronary artery calcification ;###cardiovascularHeart,Myocardial infarction ;###cardiovascularHeart,Cardiac dysfunction ;###cardiovascularHeart,Heart failure ###cardiovascularVascular,Generalized calcification of arteries, including aorta and intraparenchymal arteries ;###cardiovascularVascular,Arterial stenosis due to myointimal proliferation ;###cardiovascularVascular,Hypertension ;###cardiovascularVascular,Panarteritis (rare) ###abdomenExternalFeatures,Periumbilical pseudoxanthomatous skin lesions (in some patients) ###skeletal,Periarticular calcification (in some patients) ;###skeletal,Hypophosphatemic rickets (in some patients) ###skinNailsHairSkin,Pseudoxanthomatous skin lesions (in some patients) ###metabolicFeatures,Hypophosphatemia due to decreased renal tubular phosphate reabsorption ###miscellaneous,Most patients die in infancy ;###miscellaneous,Features of pseudoxanthoma elasticum seen in later childhood in some surviving patients ###molecularBasis,Caused by mutation in the ectonucleotide pyrophosphatase/phosphodiesterase-1 gene (ENPP1, ) 2.$$$mimNumber,615522###prefix,####preferredTitle,COLE DISEASE; COLED###inheritance,Autosomal dominant ###headAndNeckMouth,Normal teeth ###chestBreasts,Microcalcifications on mammography (in some patients) ###abdomenSpleen,Splenic calcification (in some patients) ###skeletalPelvis,Calcific tendinopathy of hips (in some patients) ###skeletalLimbs,Calcific tendinopathy of shoulders (in some patients) ;###skeletalLimbs,Calcific tendinopathy of wrists (in some patients) ###skeletalFeet,Calcific tendinopathy of heels (in some patients) ###skinNailsHairSkin,Hypopigmented macules, primarily on extremities ;###skinNailsHairSkin,Punctate palmoplantar keratoderma ###skinNailsHairSkinHistology,Hyperkeratosis ;###skinNailsHairSkinHistology,Hyperorthokeratosis ;###skinNailsHairSkinHistology,Hypergranulosis ;###skinNailsHairSkinHistology,Acanthosis ;###skinNailsHairSkinHistology,Reduction in melanin content in keratinocytes ;###skinNailsHairSkinHistology,Normal melanin content in melanocytes ;###skinNailsHairSkinHistology,Normal number of melanocytes ;###skinNailsHairSkinHistology,Small deposits of calcium in papillary dermis (in some patients) ###skinNailsHairSkinElectronMicroscopy,Increased melanosomes in cytoplasm and dendrites of melanocytes ;###skinNailsHairSkinElectronMicroscopy,Paucity of melanosomes in keratinocytes ###skinNailsHairNails,Normal nails ###skinNailsHairHair,Normal hair ###muscleSoftTissue,Calcific tendinopathy, early-onset (in some patients) ###miscellaneous,Skin lesions manifest in the first year of life ;###miscellaneous,Hair, teeth, and nails are normal ###molecularBasis,Caused by mutation in the ectonucleotide pyrophosphatase/phosphodiesterase-1 gene (ENPP1, ) 3.$$$mimNumber,601665###prefix,####preferredTitle,OBESITY###inheritance,Autosomal dominant ;###inheritance,Autosomal recessive ;###inheritance,Multifactorial ###growthWeight,Obesity ###metabolicFeatures,Obesity ;###metabolicFeatures,Reduced energy expenditure ###miscellaneous,Variable phenotypic severity ;###miscellaneous,See also leptin deficiency ()###molecularBasis,Caused by mutation in the melanocortin-4 receptor gene (MC4R, );###molecularBasis,Caused by mutation in the gamma peroxisome proliferator activated receptor gene (PPARG, );###molecularBasis,Caused by mutation in the uncoupling protein-3 gene (UCP3, );###molecularBasis,Caused by mutation in the nuclear receptor subfamily 0, group B, member 2 gene (NR0B2, );###molecularBasis,Susceptibility conferred by mutation in the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene (ENPP1, );###molecularBasis,Susceptibility conferred by mutation in the ghrelin gene (GHRL, );###molecularBasis,Susceptibility conferred by mutation in the beta-2-adrenergic receptor gene (ADRB2, );###molecularBasis,Susceptibility conferred by mutation in the beta-3-adrenergic receptor gene (ADRB3, );###molecularBasis,Susceptibility conferred by mutation in the uncoupling protein-1 gene (UCP1, );###molecularBasis,Susceptibility conferred by mutation in the uncoupling protein-2 gene (UCP2, );###molecularBasis,Susceptibility conferred by mutation in the proopiomelanocortin gene (POMC, );###molecularBasis,Susceptibility conferred by mutation in the homolog of the mouse agouti gene (AGRP, );###molecularBasis,Susceptibility conferred by mutation in the cocaine- and amphetamine-regulated transcript prepropeptide (CARTPT, )",https://www.omim.org/entry/208000;https://www.omim.org/entry/615522;https://www.omim.org/entry/125853;https://www.omim.org/entry/613312;https://www.omim.org/entry/601665,.,"Autosomal recessive;Autosomal dominant;Autosomal recessive, Autosomal dominant, Multifactorial",Het,6,132196962,C,T,.,.,PASS,0/1:22:42,52.38,"T$.t.tTTTt..,,,...t,t,T,,t.ttT.,tt,t,tT",missense_variant,ENPP1,5167,.,NM_006208.2(ENPP1):c.1682C>T(p.Ala561Val),NM_006208.2,exon17(25),NP=>NP,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,0.35,38.9,15,0.0,http://exac.broadinstitute.org/gene/ENSG00000197594,0.12762,.,1,T,0.0,B,0.001,B,0.000,N,0.999,N,3.78,6.710,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427)|ATP catabolic process (GO:0006200)|biomineral tissue development (GO:0031214)|bone remodeling (GO:0046849)|cellular phosphate ion homeostasis (GO:0030643)|cellular response to insulin stimulus (GO:0032869)|generation of precursor metabolites and energy (GO:0006091)|immune response (GO:0006955)|inorganic diphosphate transport (GO:0030505)|negative regulation of cell growth (GO:0030308)|negative regulation of fat cell differentiation (GO:0045599)|negative regulation of glucose import (GO:0046325)|negative regulation of glycogen biosynthetic process (GO:0045719)|negative regulation of insulin receptor signaling pathway (GO:0046627)|negative regulation of ossification (GO:0030279)|negative regulation of protein autophosphorylation (GO:0031953)|nucleic acid phosphodiester bond hydrolysis (GO:0090305)|nucleoside triphosphate catabolic process (GO:0009143)|phosphate-containing compound metabolic process (GO:0006796)|regulation of bone mineralization (GO:0030500)|riboflavin metabolic process (GO:0006771)|sequestering of triglyceride (GO:0030730)|small molecule metabolic process (GO:0044281)|vitamin metabolic process (GO:0006766)|water-soluble vitamin metabolic process (GO:0006767),basolateral plasma membrane (GO:0016323)|cell surface (GO:0009986)|extracellular space (GO:0005615)|integral component of membrane (GO:0016021)|integral component of plasma membrane (GO:0005887)|lysosomal membrane (GO:0005765)|plasma membrane (GO:0005886),3'-phosphoadenosine 5'-phosphosulfate binding (GO:0050656)|ATP binding (GO:0005524)|calcium ion binding (GO:0005509)|insulin receptor binding (GO:0005158)|NADH pyrophosphatase activity (GO:0035529)|nucleic acid binding (GO:0003676)|nucleoside-triphosphate diphosphatase activity (GO:0047429)|nucleotide diphosphatase activity (GO:0004551)|phosphodiesterase I activity (GO:0004528)|polysaccharide binding (GO:0030247)|protein homodimerization activity (GO:0042803)|scavenger receptor activity (GO:0005044)|zinc ion binding (GO:0008270),.,.,.,.,46,1,AX257
383,.,.,OMIM|low_frequency,"Name=GCcontent,SegmentalDuplications",.,AX257,202010;103900,"Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency;Aldosteronism, glucocorticoid-remediable","1.$$$mimNumber,202010###prefix,####preferredTitle,ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE DEFICIENCY###inheritance,Autosomal recessive ###growthHeight,Short stature ###cardiovascularVascular,Hypertension ###genitourinaryExternalGenitaliaMale,Virilization ;###genitourinaryExternalGenitaliaMale,Large penis ;###genitourinaryExternalGenitaliaMale,Small testes ###genitourinaryExternalGenitaliaFemale,Ambiguous genitalia due to virilization ;###genitourinaryExternalGenitaliaFemale,Enlarged clitoris ;###genitourinaryExternalGenitaliaFemale,Penile urethra ;###genitourinaryExternalGenitaliaFemale,Fused labial-scrotal folds ###genitourinaryInternalGenitaliaFemale,Rudimentary uterus and vagina ###genitourinaryKidneys,Adrenal hyperplasia ###skeletal,Advanced bone age ###skeletalLimbs,Premature epiphyseal closure ###skinNailsHairSkin,Hyperpigmentation associated with increased adrenocorticotropic hormone (ACTH) ###endocrineFeatures,Congenital adrenal hyperplasia ;###endocrineFeatures,Precocious puberty in males ###laboratoryAbnormalities,Increased 11-deoxycorticosterone ;###laboratoryAbnormalities,Increased 11-deoxycortisol ;###laboratoryAbnormalities,Decreased aldosterone ;###laboratoryAbnormalities,Decreased renin ;###laboratoryAbnormalities,Decreased cortisol ;###laboratoryAbnormalities,Increased ACTH ;###laboratoryAbnormalities,Increased androgens ;###laboratoryAbnormalities,Hypokalemia ###miscellaneous,Onset in neonatal period ;###miscellaneous,Incidence of 1 in 100,000 births in Caucasians ;###miscellaneous,Incidence of 1 in 5,000 to 1 in 7,000 in Moroccan Jewish individuals ;###miscellaneous,Accounts for 5 to 7% of all cases of congenital adrenal hyperplasia ###molecularBasis,Caused by mutation in the cytochrome P450, subfamily XIB, polypeptide 1 gene (CYP11B1, ) 2.$$$mimNumber,103900###prefix,####preferredTitle,HYPERALDOSTERONISM, FAMILIAL, TYPE I; HALD1###inheritance,Autosomal dominant ###cardiovascularVascular,Hypertension (suppressible by glucocorticoid treatment) ###genitourinaryKidneys,Adrenal hyperplasia ###endocrineFeatures,Increased aldosterone ###laboratoryAbnormalities,Normal or decreased serum potassium ;###laboratoryAbnormalities,Increased aldosterone ;###laboratoryAbnormalities,Low plasma renin activity ;###laboratoryAbnormalities,Increased 18-oxocortisol ;###laboratoryAbnormalities,Increased 18-hydroxycortisol ###miscellaneous,Variable phenotypic expression ;###miscellaneous,Variable age at onset (childhood to adult) ;###miscellaneous,Chimeric CYP11B1/CYP11B2 gene is an anti-Lepore-like fusion product ###molecularBasis,Caused by fusion of the cytochrome P450, subfamily XIB, polypeptide 1 gene (CYP11B1, )",https://www.omim.org/entry/202010;https://www.omim.org/entry/103900,.,Autosomal recessive;Autosomal dominant,Het,8,143961126,A,G,.,.,PASS,0/1:54:102,52.94,"GGGG,,,,,gG,,,,Gg.,g,GGGG..g,GG...G.GG.GG,g.,gGGg.ggG,g.ggg.GG.gg,.g.,.gggGgg..,.g.g,g.,,,G^]G",missense_variant;missense_variant,CYP11B1,1584,.,NM_001026213.1(CYP11B1):c.104T>C(p.Val35Ala);NM_000497.3(CYP11B1):c.104T>C(p.Val35Ala),NM_000497.3,exon1(8);exon1(9),NP=>NP;NP=>NP,0.003,0.0006,0,0,0.0003,0.0039,0.0003,0.0049,0,32,0.0037,0,32,0.00026,0.0102459016393,5/488,http://exac.broadinstitute.org/variant/8-143961126-A-G,-0.75,14.7,7,0.0,http://exac.broadinstitute.org/gene/ENSG00000160882,0.11182,.,1,T,0.115,B,0.058,B,0.665,N,1.000,N,1.77,5.894,rs201951316,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,aldosterone biosynthetic process (GO:0032342)|C21-steroid hormone biosynthetic process (GO:0006700)|cellular response to hormone stimulus (GO:0032870)|cellular response to potassium ion (GO:0035865)|cortisol biosynthetic process (GO:0034651)|glucocorticoid biosynthetic process (GO:0006704)|glucose homeostasis (GO:0042593)|immune response (GO:0006955)|mineralocorticoid biosynthetic process (GO:0006705)|regulation of blood pressure (GO:0008217)|small molecule metabolic process (GO:0044281)|steroid metabolic process (GO:0008202)|sterol metabolic process (GO:0016125)|xenobiotic metabolic process (GO:0006805),mitochondrial inner membrane (GO:0005743)|mitochondrion (GO:0005739),heme binding (GO:0020037)|iron ion binding (GO:0005506)|steroid 11-beta-monooxygenase activity (GO:0004507),.,.,.,.,28,0,AX257
